Clincosm LogoSign in Get a demo

medullary thyroid carcinoma

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

Not yet recruiting
  • Bronchial and Thymic Neuroendocrine Tumour
  • +3 more
  • Lu-177 DOTATATE (Lutathera®)
  • (no location specified)
Nov 1, 2023

Medullary Thyroid Carcinoma, Nodular Goiter Trial in Pilar (Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin

Completed
  • Medullary Thyroid Carcinoma
  • Nodular Goiter
  • Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin measurement
  • Pilar, Buenos Aires, Argentina
    Hospital Universitario Austral
Oct 5, 2023

Diabetes, Diabetes, Type 2, Medullary Thyroid Carcinoma Trial in Morgantown (No treatment given)

Enrolling by invitation
  • Diabetes
  • +3 more
  • No treatment given
  • Morgantown, West Virginia
    United BioSource, LLC
Oct 4, 2022

Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)

Not yet recruiting
  • Medullary Thyroid Cancer
  • +3 more
  • Groningen, Netherlands
    University Medical Centre Groningen
Sep 8, 2022

Medullary Thyroid Carcinoma Trial in Angers, Nantes, Saint-Herblain (• TF2 and 68 Ga-IMP-288)

Completed
  • Medullary Thyroid Carcinoma
  • • TF2 and 68 Ga-IMP-288
  • Angers, France
  • +2 more
Jul 22, 2022

Thyroid Carcinoma

Recruiting
  • Differentiated Thyroid Carcinoma
  • Medullary Thyroid Carcinoma
  • Immunohistochemistry (IHC)
  • +2 more
  • L'Hospitalet De Llobregat, Barcelona, Spain
  • +11 more
Mar 22, 2022

Medullary Thyroid Carcinoma Trial in China (HA121-28 tablets)

Recruiting
  • Medullary Thyroid Carcinoma
  • HA121-28 tablets
  • Beijing, Beijing, China
  • +12 more
Feb 7, 2022

Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Type 2A, Multiple Endocrine Neoplasia Type 2B Trial run by the NCI

Completed
Has Results
  • Medullary Thyroid Carcinoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 1, 2020

Medullary Thyroid Carcinoma Trial in Worldwide (111In-CP04, 111In-CP04 with co-administration of gelofusine/gelaspan)

Completed
  • Medullary Thyroid Carcinoma
  • 111In-CP04
  • 111In-CP04 with co-administration of gelofusine/gelaspan
  • Innsbruck, Austria
  • +4 more
Mar 19, 2020

Collection of Tissue Samples for Study of Multidrug Resistance

Completed
  • Breast Carcinoma
  • +2 more
    • Pittsburgh, Pennsylvania
      Childrens Hospital, Pittsburgh
    Dec 13, 2019

    Medullary Thyroid Carcinoma Trial in China (Anlotinib, Placebo)

    Completed
    • Medullary Thyroid Carcinoma
    • Beijing, Beijing, China
    • +18 more
    May 19, 2019

    Medullary Thyroid Carcinoma Trial run by the NCI (Bortezomib, Vandetanib)

    Terminated
    Has Results
    • Medullary Thyroid Carcinoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Nov 5, 2018

    Medullary Thyroid Carcinoma Trial in Marseille (PET at 18F-FDOPA)

    Unknown status
    • Medullary Thyroid Carcinoma
    • PET at 18F-FDOPA
    • Marseille, Paca, France
      Assistance Publique Des Hopitaux de Marseille
    Aug 16, 2018

    Molecular Pathways in Medullary Thyroid Carcinoma and

    Completed
    • Medullary Thyroid Carcinoma
    • Multiple Endocrine Neoplasia Type 2
      • Bethesda, Maryland
        National Cancer Institute (NCI), 9000 Rockville Pike
      Apr 4, 2018

      Medullary Thyroid Carcinoma Trial in Ulm (Sorafenib)

      Withdrawn
      • Medullary Thyroid Carcinoma
      • Ulm, Baden-Wuerttemberg, Germany
        University Hospital Ulm, Clinic for Nuclear Medicine
      May 16, 2013

      Pheochromocytoma, Neuroblastoma, Paraganglioma Trial in Vancouver (123I-meta-iodobenzylguanidine)

      Unknown status
      • Pheochromocytoma
      • +4 more
      • Vancouver, British Columbia, Canada
        Vancouver Coastal Health
      Jun 13, 2011